Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056
Public ClinicalTrials.gov record NCT01296711. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Open-Label, Follow-up Study to Assess the Long-Term Safety and Efficacy of CDP6038 (Olokizumab) Administered Subcutaneously to Subjects With Active Rheumatoid Arthritis Who Completed Study RA0056
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the long term safety and tolerability of CDP6038 (olokizumab) treatment in adult subjects with active rheumatoid arthritis who completed study RA0056 (NCT01242488).
Study identification
- NCT ID
- NCT01296711
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 190 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 7, 2011 (Actual)
- Primary completion
- May 1, 2013 (Actual)
- Completion
- Aug 5, 2013 (Actual)
- Last update posted
- Apr 14, 2022
2011 – 2013
United States locations
- U.S. sites
- 50
- U.S. states
- 24
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 166 | Mesa | Arizona | — | — |
| 154 | Phoenix | Arizona | — | — |
| 118 | Scottsdale | Arizona | — | — |
| 103 | Hot Springs | Arkansas | — | — |
| 127 | Covina | California | — | — |
| 148 | La Jolla | California | — | — |
| 184 | Long Beach | California | — | — |
| 177 | Los Angeles | California | — | — |
| 104 | Palo Alto | California | — | — |
| 129 | Santa Maria | California | — | — |
| 164 | Upland | California | — | — |
| 141 | Hamden | Connecticut | — | — |
| 111 | Lewes | Delaware | — | — |
| 151 | DeBary | Florida | — | — |
| 114 | Jupiter | Florida | — | — |
| 157 | Tampa | Florida | — | — |
| 183 | Tampa | Florida | — | — |
| 116 | Idaho Falls | Idaho | — | — |
| 160 | Moline | Illinois | — | — |
| 168 | Springfield | Illinois | — | — |
| 133 | Cedar Rapids | Iowa | — | — |
| 172 | Kansas City | Kansas | — | — |
| 185 | Saint Clair Shores | Michigan | — | — |
| 112 | St Louis | Missouri | — | — |
| 134 | St Louis | Missouri | — | — |
| 102 | Lincoln | Nebraska | — | — |
| 171 | Freehold | New Jersey | — | — |
| 152 | Toms River | New Jersey | — | — |
| 174 | Brooklyn | New York | — | — |
| 170 | Charlotte | North Carolina | — | — |
| 150 | Cincinnati | Ohio | — | — |
| 100 | Dayton | Ohio | — | — |
| 110 | Oklahoma City | Oklahoma | — | — |
| 165 | Duncansville | Pennsylvania | — | — |
| 105 | Nashville | Tennessee | — | — |
| 135 | Austin | Texas | — | — |
| 128 | Dallas | Texas | — | — |
| 126 | Houston | Texas | — | — |
| 132 | Houston | Texas | — | — |
| 138 | Houston | Texas | — | — |
| 181 | Houston | Texas | — | — |
| 145 | Mesquite | Texas | — | — |
| 143 | Nassau Bay | Texas | — | — |
| 122 | San Antonio | Texas | — | — |
| 144 | Tomball | Texas | — | — |
| 142 | Victoria | Texas | — | — |
| 139 | Chesapeake | Virginia | — | — |
| 175 | Tacoma | Washington | — | — |
| 136 | Beckley | West Virginia | — | — |
| 167 | Clarksburg | West Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01296711, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2022 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01296711 live on ClinicalTrials.gov.